Novo Nordisk Says FDA Also Updated Rybelsus Label To Include Additional Information From Pioneer 6 CVOT Demonstrating CV Safety; Says Rybelsus Demonstrated CV Safety By Meeting Primary Endpoint Of Non-inferiority For Composite Mace Endpoint
Benzinga Newsdesk